Cargando…

The genetic association between type 2 diabetic and hepatocellular carcinomas

BACKGROUND: Type 2 diabetes mellitus (T2DM) and hepatocellular carcinoma (HCC) are both major health problems throughout the world. It has been reported that T2DM is an independent risk factor for HCC, although the pathophysiology is still unclear. METHODS: In order to identify differentially expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Zhan, Xiao, Zunqiang, Hu, Linjun, Gao, Yuling, Zhao, Junjun, Liu, Yang, Shen, Guoliang, Xu, Qiuran, Huang, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186634/ https://www.ncbi.nlm.nih.gov/pubmed/32355824 http://dx.doi.org/10.21037/atm.2020.02.13

Ejemplares similares

Hypoxia-inducible factors in hepatocellular carcinoma
por: Guo, Yang, et al.
Publicado: (2020)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

Application of nomogram containing log odds of metastatic lymph node in gallbladder cancer patients
por: Shi, Zhan, et al.
Publicado: (2020)

Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis
por: Xiao, Zunqiang, et al.
Publicado: (2020)

Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum
por: Xiao, Zunqiang, et al.
Publicado: (2021)

Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum
por: Xiao, Zunqiang, et al.
Publicado: (2021)

TGFβ2 is a prognostic‐related biomarker and correlated with immune infiltrates in gastric cancer
por: Xiao, Zunqiang, et al.
Publicado: (2020)

Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
por: Zhao, Junjun, et al.
Publicado: (2021)

MicroRNA‐301b‐3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4
por: Guo, Yang, et al.
Publicado: (2019)

FBW7 in hematological tumors
por: Zhu, Qiaojuan, et al.
Publicado: (2020)

HIF-1/2α-Activated RNF146 Enhances the Proliferation and Glycolysis of Hepatocellular Carcinoma Cells via the PTEN/AKT/mTOR Pathway
por: Shen, Guoliang, et al.
Publicado: (2022)

Long non‐coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B‐cell lymphoma cells by targeting miR‐497‐5p/PIM1 axis
por: Zhu, Qiaojuan, et al.
Publicado: (2019)

UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway
por: Shi, Zhan, et al.
Publicado: (2021)

A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications
por: Hu, Xiaoge, et al.
Publicado: (2018)

MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib
por: Guo, Jinhui, et al.
Publicado: (2023)

Prospects of Noncoding RNAs in Hepatocellular Carcinoma
por: Zhou, Huaixiang, et al.
Publicado: (2018)

Erratum to the genetic association between type 2 diabetic and hepatocellular carcinomas
Publicado: (2022)

LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis
por: Liu, Yang, et al.
Publicado: (2021)

Glycogen Synthase Kinase-3β Is Associated with the Prognosis of Hepatocellular Carcinoma and May Mediate the Influence of Type 2 Diabetes Mellitus on Hepatocellular Carcinoma
por: Qiao, Guoliang, et al.
Publicado: (2014)

Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma
por: Gao, Shan, et al.
Publicado: (2020)

TGF-β2 is a Prognostic Biomarker Correlated with Immune Cell Infiltration in Colorectal Cancer: A STROBE-compliant article
por: Tu, Yifeng, et al.
Publicado: (2020)

Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway
por: Zhu, Ning, et al.
Publicado: (2022)

Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis
por: Hu, Linjun, et al.
Publicado: (2020)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

PKM2 regulates Gli1 expression in hepatocellular carcinoma
por: XU, QIURAN, et al.
Publicado: (2014)

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4
por: Yang, Liu, et al.
Publicado: (2018)

LncRNA ALKBH3‐AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion
por: Lu, Qiliang, et al.
Publicado: (2022)

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum
por: Yang, Liu, et al.
Publicado: (2022)

Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression
por: Shen, Cunyi, et al.
Publicado: (2021)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2022)

HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
por: Shi, Tingting, et al.
Publicado: (2021)

A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
por: Wang, Yufeng, et al.
Publicado: (2019)

Clinicopathological study of gastric schwannoma and review of related literature
por: Zhong, Zhihan, et al.
Publicado: (2022)

The transcriptional activity of Gli1 is negatively regulated by AMPK through Hedgehog partial agonism in hepatocellular carcinoma
por: XU, QIURAN, et al.
Publicado: (2014)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

Genetic alterations in hepatocellular carcinoma: An update
por: Niu, Zhao-Shan, et al.
Publicado: (2016)

[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4msn686811f758957h5korqot4